Accurate and Early Diagnosis of NSCLC Using Aberrant Fragmentomic Features of Circulating Cell-Free Mitochondrial DNA

Our multicenter study provides a novel non-invasive approach using ccf-mtDNA fragmentomics for the differential diagnosis of benign and malignant lung diseases and early diagnosis of NSCLC, with potential applications in clinical decision-making in the management of NSCLC.